Partial characterization of the woodchuck tumor suppressor, p53, and its interaction with woodchuck hepatitis virus X antigen in hepatocarcinogenesis

Oncogene

Volumn 15, Issue 3, 1997, Pages 327-336

  Feitelson, Mark A ^a   Ranganathan, Perungavur N ^a   Clayton, Marcia M ^a   Zhang, Shu Min ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Hepatocarcinogenesis; p53; Woodchuck hepatitis virus; X antigen

Indexed keywords

ANTIBODY; COMPLEMENTARY DNA; PROTEIN P53; RNA; VIRUS ANTIGEN;

ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; HEPATITIS; HEPATITIS VIRUS; IMMUNOPRECIPITATION; LIVER; LIVER CARCINOGENESIS; MOLECULAR CLONING; MONKEY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; TUMOR SUPPRESSOR GENE; VIRUS CARCINOGENESIS; VIRUS CELL INTERACTION; WOODCHUCK;

ANIMALIA; HEPADNAVIRIDAE; MARMOTA MONAX; WOODCHUCK HEPATITIS B VIRUS;

EID: 0030767654     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201203     Document Type: Article

References (57)

1. Benbrook D, Lernhardt E and Pfahl M. (1988). Nature, 333, 669-672.
2. Benn J and Schneider RJ. (1995). Proc. Natl. Acad. Sci. USA, 92, 11215-11219.
3. Bressac B, Kew M, Wands J and Ozturk M. (1991). Nature, 350, 429-431.
4. Cheong JH, Yi MK, Lin Y and Murakami S. (1995). EMBO J., 14, 143-150.
5. Chirgwin JM, Przybyla AE, MacDonald RJ and Rutter WJ. (1979). Biochemistry, 18, 5294-5299.
6. Chou PY and Fasman GD. (1974). Biochemistry, 13, 222-245.
7. Crook T, Marston NJ, Sara EA and Vousden KH. (1994). Cell, 79, 817-827.
8. Dejean A, Bougueleret L, Grzeschik KH and Tiollais P. (1986). Nature, 322, 70-72.
9. Diamantis ID, McGandy CE, Chen TJ, Liaw YF, Gudat F and Bianchi L. (1992). J. Hepatol., 15, 400-403.
10. Feitelson MA and Clayton MM. (1990). Virology, 177, 367-371.
11. Feitelson MA, Clayton MM and Blumberg BS. (1990a). Gastroenterology, 98, 1071-1078.
12. Feitelson MA, Clayton MM and Phimister B. (1990). Virology, 177, 357-366.
13. Feitelson MA, Lega L, Duan LX and Clayton MM. (1993a). J. Hepatol., 17, S24-S34.
14. Feitelson MA, Zhu M, Duan LX and London WT. (1993). Oncogene, 8, 1109-1117.
15. Fourel G, Trepo C, Bougueleret L, Henglein B, Ponzetto A, Tiollais P and Buendia MA. (1990). Nature, 347, 294-298.
16. Galibert F, Chen TN and Mandart E. (1982). J. Virol., 41, 51-65.
17. Hainaut P and Milner J. (1992). EMBO J., 11, 3513-3520.
18. Haviv I, Vaizel D and Shaul Y. (1996). EMBO J., 15, 3413-3420.
19. Hansen RS and Braithwaite AW. (1996). Oncogene, 13, 995-1007.
20. Hohne M, Schaefer S, Seifer M, Feitelson MA, Paul D and Gerlich WH. (1990). EMBO. J., 9, 1137-1145.
21. Hosono S, Lee CH, Chou MJ, Yang CS and Shih C. (1991). Oncogene, 6, 237-243.
22. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ and Harris CC. (1991). Nature, 350 427-428.
23. Hsu TY, Moroy T, Etiemble J, Louise A, Trepo C, Tiollais P and Buendia MA. (1988). Cell, 55, 627-635.
24. Huang J, Kwong K, Sun ECY and Liang TJ. (1996). J. Virol., 70, 5582-5591.
25. Koike K, Moriya K, Iino S, Yotsuyanagi H, Endo Y, Miyamura T and Kurokawa K. (1994). Hepatology, 19, 810-819.
26. Lee HS, Rajagopalan MS and Vyas GN. (1988). Hepatology, 8, 1116-1120.
27. Lee TH, Finegold MJ, Shen RF, DeMayo JL, Woo SLC and Butel JS. (1990). J. Virol., 64, 5939-5947.
28. Lee TH, Elledge SJ and Butel JS. (1995). J. Virol., 69, 1107-1114.
29. Levine AJ. (1990). Virolgy, 177, 419-426.
30. Maguire HF, Hoeffler JP and Siddiqui A. (1991). Science, 252, 842-844.
31. Matsubara K and Tokino T. (1990). Mol. Biol. Med., 7, 243-260.
32. Momand J, Zambetti GP, Olson DC, George D and Levine AJ. (1992). Cell, 69, 1237-1245.
33. Moroy T, Marchio A, Etiemble J, Trepo C, Tiollais P and Buendia MA. (1986). Nature, 324, 276-279.
34. Murakamai Y, Hayashi K, Hirohashi S and Sekiya T. (1991). Cancer Res., 51, 5520-5525.
35. Natoli G, Avantaggiati ML, Chirillo P, Puri PL, Ianni A. Balsano C and Levrero M. (1994). Oncogene, 9, 2837-2843.
36. Paterlini P, Poussin K, Kew M, Franco D and Brechot C. (1995). Hepatology, 21, 313-321.
37. Popper H, Roth L, Purcell RH, Tennant BC and Gerin JL. (1987). Proc. Natl. Acad. Sci. USA, 84, 866-870.
38. Qadri K, Maguire HF and Siddiqui A. (1995). Proc. Natl. Acad. Sci. USA, 92, 1003-1007.
39. Rivkina MB, Cullen JM, Robinson WS and Mario PL. (1994). Cancer Res., 54, 5430-5437.
40. Robinson WS. (1994). Ann. Rev. Med., 45, 297-323.
41. Seto E, Usheva A, Zambetti GP, Momand J, Horikoshi N, Weinmann R, Levine AJ and Shenk T. (1992). Proc. Natl. Acad. Sci. USA, 89, 12028-12032.
42. Shirakata Y, Kawada M, Fujiki Y, Sano H, Oda M, Yaginuma K, Kobayashi M and Koike K. (1989). Jpn. J. Cancer Res., 80, 617-621.
43. Su Q, Liu YF, Zhang JF, Zhang SX, Li DF and Yang JJ. (1994). Hepatology, 20, 788-799.
44. Summers J, Smolec JM and Snyder R. (1978). Proc. Natl. Acad. Sci. USA, 75, 4533-4537.
45. Summers J. (1981). Hepatology, 1, 179-183.
46. Truant R, Antunovic J, Greenblatt J, Prives C and Cromlish JA. (1995). J. Virol., 69, 1851-1859.
47. Ueda H, Ullrich SJ, Ganemi JD, Kappel CA, Ngo L, Feitelson MA and Jay G. (1995). Nature Genetics, 9, 41-47.
48. Ueda K and Ganem D. (1996). J. Virol., 70, 1375-1383.
49. Ullrich SJ, Mercer WE and Appella E. (1992). Oncogene, 7, 1635-1643.
50. Wang J, Zindy F, Chenivesse X, Lamas E, Henglein B and Brechot C. (1992). Oncogene, 7, 1653-1656.
51. Wang W, London WT and Feitelson MA. (1991a). Cancer Res., 51, 4971-4977.
52. Wang W, London WT, Lega L and Feitelson MA. (1991). Hepatology, 14, 29-37.
53. Wang XW, Forrester K, Yeh H, Feitelson MA, Gu JR and Harris CC. (1994). Proc. Natl. Acad. Sci. USA, 91, 2230-2234.
54. Wollersheim M, Debelka U and Hofschneider PH. (1988). Oncogene, 3, 545-552.
55. Zahm P, Hofschneider PH and Koshy R. (1988). Oncogene, 3, 169-177.
56. Zauberman A, Lupo A and Oren M. (1995). Oncogene, 10, 2361-2366.
57. Zhou YZ, Slagle BL, Donehower LA, vanTuinen P, Ledbetter DH and Butel JS. (1988). J. Virol., 62, 4224-4231.